Solventum Co. (NYSE:SOLV) Shares Sold by Cherry Tree Wealth Management LLC

Cherry Tree Wealth Management LLC cut its stake in Solventum Co. (NYSE:SOLV) by 7.4% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,875 shares of the company’s stock after selling 150 shares during the period. Cherry Tree Wealth Management LLC’s holdings in Solventum were worth $124,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently bought and sold shares of the stock. Modus Advisors LLC purchased a new position in Solventum during the 4th quarter worth approximately $25,000. Stonebridge Financial Group LLC purchased a new position in shares of Solventum during the 4th quarter valued at approximately $26,000. True Wealth Design LLC increased its holdings in shares of Solventum by 23,550.0% during the 3rd quarter. True Wealth Design LLC now owns 473 shares of the company’s stock valued at $33,000 after purchasing an additional 471 shares in the last quarter. Crews Bank & Trust purchased a new position in shares of Solventum during the 4th quarter valued at approximately $32,000. Finally, Prospera Private Wealth LLC purchased a new position in shares of Solventum during the 3rd quarter valued at approximately $35,000.

Analysts Set New Price Targets

Several brokerages recently commented on SOLV. Mizuho initiated coverage on shares of Solventum in a report on Wednesday, December 4th. They issued a “neutral” rating and a $70.00 price target for the company. Morgan Stanley boosted their price objective on shares of Solventum from $60.00 to $73.00 and gave the company an “equal weight” rating in a report on Monday, November 11th. Finally, Piper Sandler boosted their price target on shares of Solventum from $71.00 to $75.00 and gave the stock a “neutral” rating in a research note on Friday, November 8th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and one has assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $68.29.

Solventum Price Performance

Shares of SOLV opened at $73.08 on Monday. The company has a debt-to-equity ratio of 2.45, a current ratio of 1.15 and a quick ratio of 0.83. The company’s fifty day moving average is $71.14 and its two-hundred day moving average is $69.24. Solventum Co. has a 1 year low of $47.16 and a 1 year high of $96.05.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.